Article info
Electronic pages
Correspondence
Impact of genetic predisposition of de novo uveitis with etanercept in ankylosing spondylitis
- Correspondence to Professor Hubert Marotte, Department of Rheumatology, Hôpital Nord, University Hospital of Saint-Etienne, 42055 Saint-Etienne, Cedex 02, France; hubert.marotte{at}chu-st-etienne.fr
Citation
Impact of genetic predisposition of de novo uveitis with etanercept in ankylosing spondylitis
Publication history
- Received October 12, 2014
- Revised October 29, 2014
- Accepted November 7, 2014
- First published December 2, 2014.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions